Becker's Healthcare December 10, 2019
Alia Paavola

Civica Rx, the nonprofit generic drug company formed by several major health systems, will have eight critical injectable medicines available for its member hospitals by year-end.

The injectables, many of which are in shortage, were manufactured by Hikma Pharmaceuticals.

The medications that will be available to Civica’s member hospitals include:

  • Heparin, an anticoagulant that has been in shortage
  • Naloxone hydrochloride injection, an opioid antagonist
  • Dexamethasone sodium phosphate injection, a steroid used to treat allergic reactions, blood diseases, certain cancers, among other conditions
  • Glycopyrrolate injection, used in surgeries to reduce airway secretions or prevent heart rhythm problems during surgery
  • Prochlorperazine edisylate injection, used to control severe nausea and vomiting
  • Ondansetron injection, also used to prevent nausea and vomiting
  • Morphine sulfate...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Provider
Pfizer shifts creative to Publicis in latest marketing move
Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours
Listen: What the mifepristone case means, GLP-1 skepticism, & Chinese biotech
Understanding the politics of drug pricing in the United States
FDA approves Akebia anemia pill, two years after rejection

Share This Article